Barbara Ryan is of MiNK Therapeutics, Inc.. Currently has a direct ownership of 126,107 shares of INKT, which is worth approximately $90,797. The most recent transaction as insider was on Sep 03, 2024, when has been sold 21,649 shares (Common Stock) at a price of $0.82 per share, resulting in proceeds of $17,752. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 126K
20.73% 3M change
147.93% 12M change
Total Value Held $90,797

Barbara Ryan Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 03 2024
BUY
Grant, award, or other acquisition
$17,752 $0.82 p/Share
21,649 Added 14.65%
126,107 Common Stock
Jun 03 2024
BUY
Grant, award, or other acquisition
$17,662 $0.99 p/Share
17,841 Added 14.59%
104,458 Common Stock
Mar 01 2024
BUY
Grant, award, or other acquisition
$17,750 $0.95 p/Share
18,685 Added 17.74%
86,617 Common Stock
Dec 01 2023
BUY
Grant, award, or other acquisition
$17,750 $1.04 p/Share
17,068 Added 20.08%
67,932 Common Stock
Sep 01 2023
BUY
Grant, award, or other acquisition
$17,750 $1.46 p/Share
12,158 Added 19.29%
50,864 Common Stock
Jun 01 2023
BUY
Grant, award, or other acquisition
$17,751 $1.76 p/Share
10,086 Added 20.58%
38,930 Common Stock
Mar 01 2023
BUY
Grant, award, or other acquisition
$17,750 $2.09 p/Share
8,493 Added 22.75%
28,844 Common Stock
Dec 01 2022
BUY
Grant, award, or other acquisition
$17,750 $2.61 p/Share
6,801 Added 25.05%
20,351 Common Stock
Sep 15 2022
BUY
Grant, award, or other acquisition
$35,501 $2.62 p/Share
13,550 Added 50.0%
13,550 Common Stock

Also insider at

INVO
INVO Bioscience, Inc. Healthcare
AZTR
Azitra Inc
BR

Barbara Ryan

New York, NY

Track Institutional and Insider Activities on INKT

Follow MiNK Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells INKT shares.

Notify only if

Insider Trading

Get notified when an Mi Nk Therapeutics, Inc. insider buys or sells INKT shares.

Notify only if

News

Receive news related to MiNK Therapeutics, Inc.

Track Activities on INKT